CERT

MKT CAP:$987M

Certara, Inc.

Market Cap

$987M

Healthcare·Medical - Healthcare Information Services·🇺🇸 United States·NASDAQ

Healthcare·Medical·🇺🇸·NASDAQ

Stock Price

$6.38-$2.36 (-27.00%)

Apr 22, 2026

Company Details

Certara, Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. It offers medicines to patients using b...

CEO

Jon Resnick

IPO Date

Dec 11, 2020

Website

www.certara.com

Key Metrics TTM

Revenue

$416M

+11.5% YoY

Net Income

$11M

EPS (Diluted)

$0.07

Free Cash Flow

$105M

Revenue / Share

$2.59

Gross Margin

61.4%

Operating Margin

6.3%

Net Margin

2.6%

FCF Margin

25.3%

P/S

2.4x

P/E

90.8x

Earnings Reports

Q4 2025

May 11, 2026

PENDING

FY 2025

Feb 26, 2026

$419M+8.7%EPS -$0.01

Q3 2025

Nov 6, 2025

$105M+10.3%EPS $0.01

Q2 2025

Aug 6, 2025

$105M+12.1%EPS -$0.01

Q1 2025

May 5, 2025

$106M+9.7%EPS $0.03

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q4 21	$75M	$46M	$3M
Q1 22	$82M	$49M	$6M
Q2 22	$83M	$48M	$4M
Q3 22	$85M	$52M	$11M
Q4 22	$87M	$55M	$11M
Q1 23	$90M	$55M	$7M
Q2 23	$90M	$54M	$13M
Q3 23	$86M	$50M	-$53M
Q4 23	$88M	$54M	-$8M
Q1 24	$97M	$57M	-$1M
Q2 24	$93M	$54M	-$9M
Q3 24	$95M	$58M	$3M
Q4 24	$100M	$62M	$6M
Q1 25	$106M	$64M	$8M
Q2 25	$105M	$64M	$10M
Q3 25	$105M	$65M	$3M

Valuation

Quarter	P/S	P/E
Q4 21	3.5x	—
Q1 22	3.3x	—
Q2 22	3.1x	—
Q3 22	3.0x	—
Q4 22	2.9x	67.0x
Q1 23	2.9x	71.1x
Q2 23	2.8x	51.5x
Q3 23	2.8x	—
Q4 23	2.8x	—
Q1 24	2.7x	—
Q2 24	2.7x	—
Q3 24	2.6x	—
Q4 24	2.6x	—
Q1 25	2.5x	—
Q2 25	2.4x	123.7x
Q3 25	2.4x	90.8x

Operating Cash Flow

Quarter	Operating CF	Free CF
Q4 21	$21M	$21M
Q1 22	$10M	$9M
Q2 22	$23M	$23M
Q3 22	$24M	$21M
Q4 22	$35M	$32M
Q1 23	$10M	$7M
Q2 23	$18M	$18M
Q3 23	$31M	$31M
Q4 23	$23M	$22M
Q1 24	$4M	$4M
Q2 24	$10M	$9M
Q3 24	$17M	$17M
Q4 24	$49M	$44M
Q1 25	$17M	$12M
Q2 25	$18M	$18M
Q3 25	$32M	$32M

Capital Expenditures

Quarter	CapEx
Q4 21	$148.0K
Q1 22	$506.0K
Q2 22	$353.0K
Q3 22	$3M
Q4 22	$3M
Q1 23	$3M
Q2 23	$271.0K
Q3 23	$311.0K
Q4 23	$878.0K
Q1 24	$619.0K
Q2 24	$427.0K
Q3 24	$164.0K
Q4 24	$6M
Q1 25	$6M
Q2 25	$64.0K
Q3 25	$221.0K

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q4 21	+16.6%	-39.1%
Q1 22	+22.2%	+23.4%
Q2 22	+18.1%	+21.3%
Q3 22	+14.5%	-1.2%
Q4 22	+15.0%	+4.7%
Q1 23	+10.7%	+9.9%
Q2 23	+9.3%	-1.5%
Q3 23	+1.0%	+87.4%
Q4 23	+1.6%	+28.2%
Q1 24	+7.0%	+18.2%
Q2 24	+3.2%	+32.2%
Q3 24	+10.8%	-33.3%
Q4 24	+14.0%	-2.2%
Q1 25	+9.7%	+0.4%
Q2 25	+12.1%	-7.2%
Q3 25	+10.3%	+10.2%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q4 21	$9M	11.5%
Q1 22	$8M	9.2%
Q2 22	$10M	11.5%
Q3 22	$7M	8.0%
Q4 22	$7M	7.5%
Q1 23	$9M	9.5%
Q2 23	$4M	4.0%
Q3 23	$9M	10.1%
Q4 23	$8M	8.5%
Q1 24	$9M	9.4%
Q2 24	$10M	10.5%
Q3 24	$8M	8.6%
Q4 24	$8M	7.7%
Q1 25	$7M	6.7%
Q2 25	$8M	7.9%
Q3 25	$10M	9.2%

OpEx Breakdown

Quarter	R&D	G&A	S&M
Q4 21	$7M	$19M	$7M
Q1 22	$8M	$18M	$6M
Q2 22	$8M	$19M	$6M
Q3 22	$6M	$17M	$6M
Q4 22	$7M	$18M	$8M
Q1 23	$9M	$20M	$8M
Q2 23	$8M	$14M	$8M
Q3 23	$9M	$28M	$7M
Q4 23	$8M	$34M	$9M
Q1 24	$12M	$23M	$11M
Q2 24	$9M	$28M	$12M
Q3 24	$8M	$22M	$11M
Q4 24	$8M	$21M	$13M
Q1 25	$11M	$20M	$13M
Q2 25	$9M	$17M	$14M
Q3 25	$10M	$25M	$13M

Revenue Segments

Quarter	Reportable Segment
Q1 25	$106M
Q2 25	$105M
Q3 25	$105M

Revenue by Geography

Quarter	Americas	Asia Pac	Emea	Asia Pacific
Q1 22	$60M	$6M	$16M	—
Q2 22	$63M	—	$14M	$7M
Q3 22	$64M	—	$13M	$7M
Q4 22	$66M	—	$14M	$6M
Q1 23	$67M	—	$17M	$6M
Q2 23	$68M	—	$15M	$7M
Q3 23	$65M	—	$15M	$6M
Q4 23	$65M	—	$17M	$6M
Q1 24	$69M	—	$21M	$7M
Q2 24	$70M	—	$17M	$6M
Q3 24	$70M	—	$18M	$7M
Q1 25	$72M	—	$26M	$8M
Q2 25	$73M	—	$23M	$8M
Q3 25	$74M	—	$22M	$9M

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 22	$184M	$0	$184M
Q2 22	$195M	$0	$195M
Q3 22	$211M	$0	$211M
Q4 22	$237M	$0	$237M
Q1 23	$244M	$0	$244M
Q2 23	$245M	$0	$245M
Q3 23	$272M	$0	$272M
Q4 23	$235M	$0	$235M
Q1 24	$225M	$0	$225M
Q2 24	$225M	$0	$225M
Q3 24	$233M	$0	$233M
Q4 24	$179M	$0	$179M
Q1 25	$179M	$0	$179M
Q2 25	$162M	$0	$162M
Q3 25	$173M	$0	$173M
Q4 25	$189M	$0	$189M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q4 21	156M	+4.4%	+14.6%
Q1 22	159M	+2.3%	+4.7%
Q2 22	156M	-1.7%	+6.1%
Q3 22	160M	+2.0%	+7.1%
Q4 22	159M	-0.2%	+2.3%
Q1 23	160M	+0.3%	+0.4%
Q2 23	160M	+0.1%	+2.2%
Q3 23	159M	-0.5%	-0.3%
Q4 23	159M	+0.2%	+0.1%
Q1 24	160M	+0.1%	-0.1%
Q2 24	161M	+0.6%	+0.4%
Q3 24	161M	+0.1%	+0.9%
Q4 24	161M	+0.4%	+1.2%
Q1 25	161M	+0.1%	+1.1%
Q2 25	161M	-0.3%	+0.3%
Q3 25	161M	-0.2%	-0.0%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q4 21	$67.6K	1K
Q1 22	$73.2K	1K
Q2 22	$74.3K	1K
Q3 22	$76.0K	1K
Q4 22	$72.0K	1K
Q1 23	$75.0K	1K
Q2 23	$75.1K	1K
Q3 23	$71.1K	1K
Q4 23	$62.9K	1K
Q1 24	$69.0K	1K
Q2 24	$66.7K	1K
Q3 24	$67.7K	1K
Q4 24	$64.9K	2K
Q1 25	$68.6K	2K
Q2 25	$67.6K	2K
Q3 25	$67.7K	2K

Revenue / Employee